{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:38:27Z","timestamp":1788115107928,"version":"build-2803163510"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0166277","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T18:30:35Z","timestamp":1479407435000},"page":"e0166277","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Disease Type- and Status-Specific Alteration of CSF Metabolome Coordinated with Clinical Parameters in Inflammatory Demyelinating Diseases of CNS"],"prefix":"10.1371","volume":"11","author":[{"given":"Soo Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Hye","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Soo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Yup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"issue":"9451","key":"ref1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"VA Lennon","year":"2004","journal-title":"The Lancet"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"VA Lennon","year":"2005","journal-title":"The Journal of experimental medicine"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458511406165","article-title":"The differential diagnosis of longitudinally extensive transverse myelitis","volume":"18","author":"J Kitley","year":"2012","journal-title":"Multiple Sclerosis Journal"},{"key":"ref4","article-title":"Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis","author":"J-W Hyun","year":"2014","journal-title":"Multiple Sclerosis Journal"},{"issue":"20","key":"ref5","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1021\/ac301243k","article-title":"Toward a predictive model of Alzheimer\u2019s disease progression using capillary electrophoresis\u2014mass spectrometry metabolomics","volume":"84","author":"C Ib\u00e1\u00f1ez","year":"2012","journal-title":"Analytical chemistry"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1177\/1352458513516528","article-title":"Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis","volume":"20","author":"S Reinke","year":"2014","journal-title":"Multiple Sclerosis Journal"},{"issue":"48","key":"ref7","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/onc.2011.196","article-title":"Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis","volume":"30","author":"P Storm","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13059-015-0599-z","article-title":"Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach","volume":"16","author":"A Castellanos-Mart\u00edn","year":"2015","journal-title":"Genome biology"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jprot.2011.10.027","article-title":"Recent and potential developments of biofluid analyses in metabolomics","volume":"75","author":"A Zhang","year":"2012","journal-title":"Journal of proteomics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2015.01.001","article-title":"Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology","volume":"279","author":"J Kang","year":"2015","journal-title":"Journal of neuroimmunology"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"CH Polman","year":"2011","journal-title":"Annals of neurology"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"DM Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"ref13","first-page":"1","article-title":"High quality metabolomic data for Chlamydomonas reinhardtii","volume":"4","author":"DY Lee","year":"2008","journal-title":"Plant methods"},{"issue":"24","key":"ref14","doi-asserted-by":"crossref","first-page":"10038","DOI":"10.1021\/ac9019522","article-title":"FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography\/mass spectrometry","volume":"81","author":"T Kind","year":"2009","journal-title":"Analytical chemistry"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"e68831","DOI":"10.1371\/journal.pone.0068831","article-title":"Distinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondria","volume":"8","author":"DY Lee","year":"2013","journal-title":"PloS one"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"e36637","DOI":"10.1371\/journal.pone.0036637","article-title":"Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition","volume":"7","author":"I-S Song","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"A Saeed","year":"2003","journal-title":"Biotechniques"},{"issue":"W1","key":"ref18","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0\u2014making metabolomics more meaningful","volume":"43","author":"J Xia","year":"2015","journal-title":"Nucleic acids research"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","article-title":"Translational biomarker discovery in clinical metabolomics: an introductory tutorial","volume":"9","author":"J Xia","year":"2013","journal-title":"Metabolomics"},{"issue":"27","key":"ref20","doi-asserted-by":"crossref","first-page":"23637","DOI":"10.1074\/jbc.R110.173617","article-title":"Extending biochemical databases by metabolomic surveys","volume":"286","author":"O Fiehn","year":"2011","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1074\/mcp.M111.016733","article-title":"System response of metabolic networks in Chlamydomonas reinhardtii to total available ammonium","volume":"11","author":"DY Lee","year":"2012","journal-title":"Molecular & Cellular Proteomics"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"e0152935","DOI":"10.1371\/journal.pone.0152935","article-title":"Contribution of Drosophila TRPA1 to Metabolism","volume":"11","author":"J-E Lee","year":"2016","journal-title":"PloS one"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome research"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pone.0000595","article-title":"Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid","volume":"2","author":"NW Lutz","year":"2007","journal-title":"PLoS One"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11306-011-0306-3","article-title":"Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis","volume":"8","author":"MJ Noga","year":"2012","journal-title":"Metabolomics"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jnnp.73.3.246","article-title":"A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the \u201cCari Loder regime\u201d) in the treatment of multiple sclerosis","volume":"73","author":"D Wade","year":"2002","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/249101","article-title":"Current and future therapies for multiple sclerosis","volume":"2013","author":"A Minagar","year":"2013","journal-title":"Scientifica"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0306-9877(02)00261-X","article-title":"Treatment of multiple sclerosis with lofepramine, l-phenylalanine and vitamin B 12: mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems","volume":"59","author":"C Loder","year":"2002","journal-title":"Medical hypotheses"},{"issue":"33","key":"ref29","doi-asserted-by":"crossref","first-page":"28017","DOI":"10.1074\/jbc.M112.383380","article-title":"Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor \u03baB (NF-\u03baB) and extracellular signal-regulated kinase 1 and 2 (ERK1\/2) and mitogen stress-activated kinase 1 (MSK1) signaling","volume":"287","author":"H Peng","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"17","key":"ref30","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMc1211805","article-title":"PML in a patient treated with fumaric acid","volume":"368","author":"U Ermis","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"ref31","first-page":"153","article-title":"Prognosis of Neurological Diseases","author":"G Filippini","year":"2015"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neures.2008.01.005","article-title":"Lactic acid increases aquaporin 4 expression on the cell membrane of cultured rat astrocytes","volume":"61","author":"T Morishima","year":"2008","journal-title":"Neuroscience research"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"S Jarius","year":"2011","journal-title":"Journal of the neurological sciences"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.mehy.2013.10.011","article-title":"Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: A potential link","volume":"81","author":"S Jarius","year":"2013","journal-title":"Medical hypotheses"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/jn\/117.10.1671","article-title":"Toxicity of palmitoyl glycerol to mice: hypothermia and reversal of the toxicity","volume":"117","author":"SR Siddhanti","year":"1987","journal-title":"The Journal of nutrition"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/jn\/117.10.1780","article-title":"Toxicity of palmitoyl glycerol to mice: depression of thyroid function","volume":"117","author":"PR Trumbo","year":"1987","journal-title":"The Journal of nutrition"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11306-006-0037-z","article-title":"Statistical strategies for avoiding false discoveries in metabolomics and related experiments","volume":"2","author":"DI Broadhurst","year":"2006","journal-title":"Metabolomics"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"M Stangel","year":"2013","journal-title":"Nature reviews Neurology"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS)","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(06)70552-X","article-title":"Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study","volume":"5","author":"LF Barcellos","year":"2006","journal-title":"The Lancet Neurology"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1474-4422(10)70135-6","article-title":"Emerging effects of comorbidities on multiple sclerosis","volume":"9","author":"RA Marrie","year":"2010","journal-title":"The Lancet Neurology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"159680","DOI":"10.6064\/2012\/159680","article-title":"Role of hydrogen sulfide in the pathology of inflammation","volume":"2012","author":"M Bhatia","year":"2012","journal-title":"Scientifica"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbrc.2004.11.110","article-title":"Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?","volume":"326","author":"M Whiteman","year":"2005","journal-title":"Biochemical and biophysical research communications"},{"issue":"5 part 1","key":"ref44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0016-5085(83)90203-2","article-title":"Increased blood-brain transfer in a rabbit model of acute liver failure","volume":"84","author":"ME Horowitz","year":"1983","journal-title":"Gastroenterology"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1471-4159.1987.tb04107.x","article-title":"Biotin Transport Through the Blood-Brain Barrier","volume":"48","author":"R Spector","year":"1987","journal-title":"Journal of neurochemistry"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/ncpneuro1009","article-title":"Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis","volume":"5","author":"LR Mehta","year":"2009","journal-title":"Nature Clinical Practice Neurology"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.52.1.18","article-title":"A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis","volume":"52","author":"D Bates","year":"1989","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneurol.2012.283","article-title":"\u03c9-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial","volume":"69","author":"\u00d8 Torkildsen","year":"2012","journal-title":"Archives of neurology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/srep00079","article-title":"Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis","volume":"1","author":"LP Shriver","year":"2011","journal-title":"Scientific reports"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"e002170","DOI":"10.1136\/bmjopen-2012-002170","article-title":"A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial","volume":"3","author":"MC Pantzaris","year":"2013","journal-title":"BMJ open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0166277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:02:05Z","timestamp":1588975325000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0166277"}},"subtitle":[],"editor":[{"given":"Robyn S","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0166277","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]}}}